Biocene thoughts
Dr. Shelby, 0xsmac, Vega Shah, Fabio Boniolo, Digital BiologySolarpunk stan | houses become our hospitals and data becomes our doctors | making a therapeutic is like launching a rocket
| Platform |  | Pricing | Only free issues |
|---|---|---|---|
| Publishes | Weekly | Issues | 28 |
| Subscribers | Read | shelbyann.substack.com |
Curious about how many subscribers Biocene thoughts has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Commercializing Autonomous Science
Autonomous science is a theme us at Compound have been obsessed with for years (recent post and past futuristic writing). Recently my colleague Mackenzie published an extensive piece on how automated science breakthroughs are traversing log...
Predicting protein dynamics, moats and commercialization
## Bridging the target and phenotype gap
A Biohacker Future
Biohacking will change the world sooner that what people think.
Briefly Bio comes out of stealth!
On Wednesday, Briefly Bio announced their pre-seed raise of $1.2M with ambition to become Github for Science.
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Investor @Compound | Cambridge PhD @plantsciences
your favorite alts favorite alt
I work in AI for Life Sciences & Healthcare at NVIDIA. Scientist by training, I write about the present and the future. Views are all mine.
Computational scientist with background in tissue engineering, regenerative medicine and oncology. On a long standing quest to combine creativity and ingenuity to find solutions to the most pressing issues in healthcare and medicine
Thoughts of Maximilian Lombardo Currently working at the intersection of Tech/Product/Bio/AI at Chan Zuckerberg Initiative Formerly comp bio at Kallyope
Frequently Asked Questions
How can I access the email archive for Biocene thoughts ?
You can find recent issues that have been published by Biocene thoughts on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Biocene thoughts have?
To see how many people subscribe to Biocene thoughts , simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Biocene thoughts ?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biocene thoughts as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Biocene thoughts ?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biocene thoughts using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Biocene thoughts ?
Scroll up to where it says Similar Newsletters to see other publications like Biocene thoughts . You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Biocene thoughts ?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.